Biomedical Research Enters the Marketplace

Publisher Website
Google Scholar
Abstract
THE past few years have witnessed a virtual explosion of "technology transfer" as researchers and industrialists have moved with unprecedented speed and determination to exploit molecular biology in a search for useful and profitable products based on recombinant DNA and monoclonal antibodies—technologies whose conceptual roots are in university-based science. One anticipates the rapid development of much-needed therapeutic agents including human insulin, hepatitis B antigen, somatostatin, human growth hormone, and interferon. New applications of enzymes in industrial chemistry and of hormones in agriculture are also near. Universities are warily but hopefully looking at industry as an untapped source of support for . . .